USA law protects Americans from discrimination in health insurance and employment with the
Genetic Information Nondiscrimination Act (GINA) of 2008.
NIH – National Human Genome Research Institute: an overview and resources regarding the Genetic Information Nondiscrimination Act of 2008.
Thanks to CCHMC for the information they provided below regarding their aHUS Diagnostics Program.
Cincinnati Children’s Hospital Medical Center offers a broad platform of molecular and cellular diagnostic testing for thrombotic microangiopathies (TMA), including atypical hemolytic uremic syndrome (aHUS) and thrombotic thrombocytopenia purpura (TTP). Test results are incorporated in a customized summary, where clinical information is incorporated with the genetic, biochemical and functional test results.
Cincinnati Children’s has board-certified pediatric nephrologists, hematologists, molecular geneticists and genetic counselors to provide telephone or email consultations to referring physicians regarding test selection, clinical interpretation, medical management and follow-up testing, genetic counseling, and additional studies of at-risk family members
General Contact Information for Cincinnati Children’s:
Phone: 513-636-4530 Fax: 513-636-8924 Email: firstname.lastname@example.org
Contact the thrombotic microangiopathy team:
Dr. Ralph A. Gruppo Director, Comprehensive Hemophilia and Thrombosis Center
Phone: 513-636-4269 Email: email@example.com
Dr. Bradley P. Dixon
Phone: 513-636-4531 Email: firstname.lastname@example.org
Click HERE to enter Cincinnati Children's SITE